de BlackRock ANI Pharmaceuticals ANIP Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 245 M | Comprar |
2,958,646
+211,154
| +8% | +USD 16.9 M | ﹤0.01% | 1671 |
|
|
2026
Q1 | USD 211 M | Comprar |
2,747,492
+85,780
| +3% | +USD 6.7 M | ﹤0.01% | 1638 |
|
|
2025
Q4 | USD 210 M | Comprar |
2,661,712
+112,820
| +4% | +USD 9.8 M | ﹤0.01% | 1652 |
|
|
2025
Q3 | USD 233 M | Vender |
2,548,892
-31,645
| -1% | -USD 2.58 M | ﹤0.01% | 1579 |
|
|
2025
Q2 | USD 168 M | Vender |
2,580,537
-66,093
| -2% | -USD 4.3 M | ﹤0.01% | 1729 |
|
|
2025
Q1 | USD 177 M | Vender |
2,646,630
-91,942
| -3% | -USD 5.49 M | ﹤0.01% | 1671 |
|
|
2024
Q4 | USD 151 M | Comprar |
2,738,572
+48,860
| +2% | +USD 2.81 M | ﹤0.01% | 1820 |
|
|
2024
Q3 | USD 160 M | Comprar |
2,689,712
+33,197
| +1% | +USD 2.03 M | ﹤0.01% | 1787 |
|
|
2024
Q2 | USD 169 M | Comprar |
2,656,515
+125,172
| +5% | +USD 8.13 M | ﹤0.01% | 1713 |
|
|
2024
Q1 | USD 175 M | Comprar |
2,531,343
+6,450
| +0.3% | +USD 389 k | ﹤0.01% | 1733 |
|
|
2023
Q4 | USD 139 M | Comprar |
2,524,893
+23,923
| +1% | +USD 1.32 M | ﹤0.01% | 1891 |
|
|
2023
Q3 | USD 145 M | Comprar |
2,500,970
+367,870
| +17% | +USD 21.2 M | ﹤0.01% | 1756 |
|
|
2023
Q2 | USD 115 M | Comprar |
2,133,100
+191,402
| +10% | +USD 8.48 M | ﹤0.01% | 1955 |
|
|
2023
Q1 | USD 77.1 M | Vender |
1,941,698
-41,907
| -2% | -USD 1.77 M | ﹤0.01% | 2178 |
|
|
2022
Q4 | USD 79.8 M | Comprar |
1,983,605
+58,503
| +3% | +USD 2.2 M | ﹤0.01% | 2158 |
|
|
2022
Q3 | USD 61.9 M | Vender |
1,925,102
-53,391
| -3% | -USD 1.83 M | ﹤0.01% | 2288 |
|
|
2022
Q2 | USD 58.7 M | Comprar |
1,978,493
+125,030
| +7% | +USD 3.61 M | ﹤0.01% | 2378 |
|
|
2022
Q1 | USD 52.1 M | Comprar |
1,853,463
+166,850
| +10% | +USD 6.22 M | ﹤0.01% | 2564 |
|
|
2021
Q4 | USD 77.7 M | Comprar |
1,686,613
+174,984
| +12% | +USD 7.52 M | ﹤0.01% | 2372 |
|
|
2021
Q3 | USD 49.6 M | Vender |
1,511,629
-33,651
| -2% | -USD 1.05 M | ﹤0.01% | 2667 |
|
|
2021
Q2 | USD 54.2 M | Vender |
1,545,280
-106,005
| -6% | -USD 3.61 M | ﹤0.01% | 2644 |
|
|
2021
Q1 | USD 59.7 M | Comprar |
1,651,285
+62,057
| +4% | +USD 1.94 M | ﹤0.01% | 2511 |
|
|
2020
Q4 | USD 46.2 M | Comprar |
1,589,228
+74,231
| +5% | +USD 2.13 M | ﹤0.01% | 2527 |
|
|
2020
Q3 | USD 42.7 M | Vender |
1,514,997
-12,327
| -0.8% | -USD 367 k | ﹤0.01% | 2393 |
|
|
2020
Q2 | USD 49.4 M | Comprar |
1,527,324
+70,475
| +5% | +USD 2.53 M | ﹤0.01% | 2259 |
|
|
2020
Q1 | USD 59.4 M | Vender |
1,456,849
-90,900
| -6% | -USD 4.83 M | ﹤0.01% | 1957 |
|
|
2019
Q4 | USD 95.4 M | Comprar |
1,547,749
+9,199
| +0.6% | +USD 609 k | ﹤0.01% | 1987 |
|
|
2019
Q3 | USD 112 M | Comprar |
1,538,550
+108,818
| +8% | +USD 8.14 M | ﹤0.01% | 1828 |
|
|
2019
Q2 | USD 118 M | Comprar |
1,429,732
+69,621
| +5% | +USD 4.95 M | 0.01% | 1797 |
|
|
2019
Q1 | USD 95.9 M | Vender |
1,360,111
-8,557
| -0.6% | -USD 503 k | ﹤0.01% | 1889 |
|
|
2018
Q4 | USD 61.6 M | Vender |
1,368,668
-17,686
| -1% | -USD 927 k | ﹤0.01% | 2106 |
|
|
2018
Q3 | USD 78.4 M | Vender |
1,386,354
-4,820
| -0.3% | -USD 295 k | ﹤0.01% | 2126 |
|
|
2018
Q2 | USD 92.9 M | Comprar |
1,391,174
+94,786
| +7% | +USD 5.92 M | ﹤0.01% | 1994 |
|
|
2018
Q1 | USD 75.5 M | Comprar |
1,296,388
+22,037
| +2% | +USD 1.4 M | ﹤0.01% | 2021 |
|
|
2017
Q4 | USD 82.1 M | Comprar |
1,274,351
+70
| +0% | +USD 4.36 k | ﹤0.01% | 1986 |
|
|
2017
Q3 | USD 66.9 M | Comprar |
1,274,281
+117,724
| +10% | +USD 5.61 M | ﹤0.01% | 2092 |
|
|
2017
Q2 | USD 54.1 M | Comprar |
1,156,557
+25,244
| +2% | +USD 1.22 M | ﹤0.01% | 2201 |
|
|
2017
Q1 | USD 56 M | Comprar |
1,131,313
+1,130,697
| +183,555% | +USD 63.5 M | ﹤0.01% | 2144 |
|
|
2016
Q4 | USD 37 k | Vender |
616
-152
| -20% | -USD 9.29 k | ﹤0.01% | 3060 |
|
|
2016
Q3 | USD 51 k | Comprar |
768
+123
| +19% | +USD 7.69 k | ﹤0.01% | 2942 |
|
|
2016
Q2 | USD 36 k | Comprar |
645
+168
| +35% | +USD 8.17 k | ﹤0.01% | 3069 |
|
|
2016
Q1 | USD 16 k | Comprar |
477
+328
| +220% | +USD 11.1 k | ﹤0.01% | 2945 |
|
|
2015
Q4 | USD 7 k | Mantener |
149
| – | – | ﹤0.01% | 3024 |
|
|
2015
Q3 | USD 6 k | Mantener |
149
| – | – | ﹤0.01% | 2927 |
|
|
2015
Q2 | USD 9 k | Vender |
149
-27
| -15% | -USD 1.61 k | ﹤0.01% | 2850 |
|
|
2015
Q1 | USD 11 k | Mantener |
176
| – | – | ﹤0.01% | 2669 |
|
|
2014
Q4 | USD 10 k | Mantener |
176
| – | – | ﹤0.01% | 2751 |
|
|
2014
Q3 | USD 5 k | Mantener |
176
| – | – | ﹤0.01% | 3061 |
|
|
2014
Q2 | USD 6 k | Comprar |
+176
| Nuevas | +USD 5.52 k | ﹤0.01% | 3060 |
|
Otros fondos que tienen ANIP en su cartera
TCM
Posición de BlackRock en ANIP: resumen de T2 2026
BlackRock aumentó su participación en ANI Pharmaceuticals (ANIP) en 7.7% durante T2 2026, al comprar aproximadamente USD 16.9 M y elevar la posición a 2,958,646 acciones con un valor de USD 245 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #1671.
BlackRock reportó por primera vez una posición en ANIP en T2 2014 y la ha mantenido durante 49 trimestres desde entonces. Al cierre de T2 2026, 307 fondos que sigue Wall St. Rank mantienen una posición en ANIP.
- Al cierre de T2 2026, BlackRock tenía 2,958,646 acciones de ANI Pharmaceuticals con un valor de USD 245 M.
- BlackRock compró 211,154 acciones de ANI Pharmaceuticals en T2 2026, por un monto estimado de USD 16.9 M.
- ANI Pharmaceuticals representó ﹤0.01% de la cartera de BlackRock en T2 2026 y fue su posición número 1671.
- BlackRock reportó por primera vez una posición en ANI Pharmaceuticals en T2 2014 y la ha mantenido durante 49 trimestres desde entonces.
- Al cierre de T2 2026, 307 fondos que sigue Wall St. Rank tenían ANI Pharmaceuticals en cartera.
Según el Informe 13F de BlackRock correspondiente a T2 2026, presentado el 7 ago 2026.